1 2490 87 YOGA AS AN INTERVENTION TO MANAGE MULTIPLE SCLEROSIS SYMPTOMS. MULTIPLE SCLEROSIS (MS) IS AN AUTOIMMUNE, DEMYELINATING, INFLAMMATORY DISEASE OF CENTRAL NERVOUS SYSTEM (CNS) WHICH IS CHARACTERIZED BY SPASTICITY, FATIGUE, DEPRESSION, ANXIETY, BOWEL AND BLADDER DYSFUNCTION, IMPAIRED MOBILITY, COGNITIVE IMPAIRMENT ETC. AND AFFECTS APPROXIMATELY 2.5 MILLION PEOPLE WORLDWIDE. DISEASE MODIFYING THERAPIES FOR MS WHICH HELP IN PREVENTING ACCUMULATION OF LESIONS IN WHITE MATTER OF CNS ARE COSTLY AND HAVE SIGNIFICANT ADVERSE EFFECTS. THEREFORE, PATIENTS WITH MS ARE USING COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) AND YOGA IS ONE OF THE MOST POPULAR FORM OF CAM WHICH IS BEING USED IMMENSELY TO REDUCE OR OVERCOME THE SYMPTOMS OF MS. IN THE CURRENT REVIEW ATTEMPTED TO PRESENT THE POTENTIAL IMPACT OF YOGA PRACTICES ON REDUCING MS RELATED SYMPTOMS. 2020 2 2300 43 THERAPEUTIC YOGA: SYMPTOM MANAGEMENT FOR MULTIPLE SCLEROSIS. MULTIPLE SCLEROSIS (MS) IS THE MOST COMMON AUTOIMMUNE INFLAMMATORY DEMYELINATING DISEASE OF THE CENTRAL NERVOUS SYSTEM, AFFECTING OVER 2.3 MILLION PEOPLE WORLDWIDE. ACCORDING TO THE NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE, THE AGE OF DISEASE ONSET IS TYPICALLY BETWEEN 20 AND 40 YEARS, WITH A HIGHER INCIDENCE IN WOMEN. INDIVIDUALS WITH MS EXPERIENCE A WIDE RANGE OF SYMPTOMS, INCLUDING DECLINING PHYSICAL, EMOTIONAL, AND PSYCHOLOGICAL SYMPTOMS (E.G., FATIGUE, IMBALANCE, SPASTICITY, CHRONIC PAIN, COGNITIVE IMPAIRMENT, BLADDER AND BOWEL DYSFUNCTION, VISUAL AND SPEECH IMPAIRMENTS, DEPRESSION, SENSORY DISTURBANCE, AND MOBILITY IMPAIRMENT). TO DATE, BOTH THE CAUSE OF AND CURE FOR MS REMAIN UNKNOWN. IN RECENT YEARS, MORE INDIVIDUALS WITH MS HAVE BEEN PURSUING ALTERNATIVE METHODS OF TREATMENT TO MANAGE SYMPTOMS OF THE DISEASE, INCLUDING MIND-BODY THERAPIES SUCH AS YOGA, MEDITATION, BREATHING, AND RELAXATION TECHNIQUES. IT HAS BEEN SUGGESTED THAT THE PRACTICE OF YOGA MAY BE A SAFE AND EFFECTIVE WAY OF MANAGING SYMPTOMS OF MS. THEREFORE, THE PURPOSE OF THIS PAPER IS TO SUMMARIZE THE MOST RELEVANT LITERATURE ON EXERCISE AND MIND-BODY MODALITIES TO TREAT MS SYMPTOMS AND, MORE SPECIFICALLY, THE BENEFITS AND POTENTIAL ROLE OF YOGA AS AN ALTERNATIVE TREATMENT OF SYMPTOM MANAGEMENT FOR INDIVIDUALS WITH MS. THE ARTICLE ALSO DISCUSSES FUTURE DIRECTIONS FOR RESEARCH. 2015 3 2412 29 YOGA AND ITS IMPACT ON CHRONIC INFLAMMATORY AUTOIMMUNE ARTHRITIS. RHEUMATOID ARTHRITIS (RA) IS ONE OF THE MOST COMMON CHRONIC INFLAMMATORY AUTOIMMUNE DISEASES, WHICH ADVERSELY AFFECTS THE QUALITY OF LIFE. RA IS A DISEASE OF UNKNOWN ETIOLOGY, HOWEVER, BOTH GENETIC AND ENVIRONMENTAL FACTORS APPEAR TO CONTRIBUTE TO THE SUSCEPTIBILITY TO THIS DISEASE. THE SEVERITY AND PROGRESSION OF THE DISEASE ARE ATTRIBUTABLE TO THE RELEASE OF A HOST OF INFLAMMATORY CYTOKINES, CYTOTOXIC AND IMMUNE REGULATORY FACTORS. THE TREATMENTS OF RA ARE PRIMARILY LIMITED TO SYMPTOMATIC ALLEVIATION OF PAIN OR OTHER SYMPTOMS OR TO THE USE OF CYTOTOXIC DRUG TREATMENT IN SEVERE FORMS OF THE DISEASE WHICH IS COMMONLY ASSOCIATED WITH SIGNIFICANT SIDE EFFECTS. DESPITE LACK OF A CURE, THE DISEASE MAY BE CONTROLLED BY MIND-BODY INTERVENTIONS. HOLISTIC TREATMENTS SUCH AS YOGA SIGNIFICANTLY IMPROVE AND REDUCE THE PSYCHO-SOMATIC SYMPTOMS, PAIN PERCEPTION, DISABILITY QUOTIENT, JOINT FLEXIBILITY, RANGE OF MOTION, POSTURE, MUSCLE STRENGTH, COORDINATION, AND DISEASE ACTIVITY. HERE, WE DISCUSS THE FEATURES OF RA AND ADDRESS HOW YOGA CAN BE USED AS A THERAPEUTIC REGIMEN TO IMPROVE THE QUALITY OF LIFE OF PATIENTS WITH RA. 2021 4 2460 36 YOGA AS A METHOD OF SYMPTOM MANAGEMENT IN MULTIPLE SCLEROSIS. MULTIPLE SCLEROSIS (MS) IS AN IMMUNE-MEDIATED PROCESS IN WHICH THE BODY'S IMMUNE SYSTEM DAMAGES MYELIN IN THE CENTRAL NERVOUS SYSTEM (CNS). THE ONSET OF THIS DISORDER TYPICALLY OCCURS IN YOUNG ADULTS, AND IT IS MORE COMMON AMONG WOMEN. CURRENTLY, THERE IS NO CURE AND THE LONG-TERM DISEASE PROGRESSION MAKES SYMPTOMATIC MANAGEMENT CRITICAL FOR MAINTAINING QUALITY OF LIFE. SEVERAL PHARMACOTHERAPEUTIC AGENTS ARE APPROVED FOR TREATMENT, BUT MANY PATIENTS SEEK COMPLEMENTARY AND ALTERNATIVE INTERVENTIONS. REVIEWS HAVE BEEN CONDUCTED REGARDING BROAD TOPICS SUCH AS MINDFULNESS-BASED INTERVENTIONS FOR PEOPLE DIAGNOSED WITH MS AND THE IMPACT OF YOGA ON A RANGE OF NEUROLOGICAL DISORDERS. THE OBJECTIVE OF THE PRESENT REVIEW IS TO EXAMINE THE POTENTIAL BENEFITS OF YOGA FOR INDIVIDUALS WITH MS AND ADDRESS ITS USE IN MANAGING SYMPTOMS INCLUDING PAIN, MENTAL HEALTH, FATIGUE, SPASTICITY, BALANCE, BLADDER CONTROL, AND SEXUAL FUNCTION. 2015 5 2418 22 YOGA AND MENOPAUSAL TRANSITION. WITH INCREASED LIFE EXPECTANCY, TODAY, WOMEN SPEND ONE-THIRD OF THEIR LIFE AFTER MENOPAUSE. THUS MORE ATTENTION IS NEEDED TOWARDS PERI- AND POST-MENOPAUSAL SYMPTOMS. ESTROGEN REPLACEMENT THERAPY IS THE MOST EFFECTIVE TREATMENT, HOWEVER, IT HAS ITS OWN LIMITATIONS. THE PRESENT NEED IS TO EXPLORE NEW OPTIONS FOR THE MANAGEMENT OF MENOPAUSAL SYMPTOMS. YOGIC LIFE STYLE IS A WAY OF LIVING WHICH AIMS TO IMPROVE THE BODY, MIND AND DAY TO DAY LIFE OF INDIVIDUALS. THE MOST COMMONLY PERFORMED YOGA PRACTICES ARE POSTURES (ASANA), CONTROLLED BREATHING (PRANAYAMA), AND MEDITATION (DHYANA). YOGA HAS BEEN UTILIZED AS A THERAPEUTIC TOOL TO ACHIEVE POSITIVE HEALTH AND CONTROL AND CURE DISEASES. THE EXACT MECHANISM AS TO HOW YOGA HELPS IN VARIOUS DISEASE STATES IS NOT KNOWN. THERE COULD BE NEURO-HORMONAL PATHWAYS WITH A SELECTIVE EFFECT IN EACH PATHOLOGICAL SITUATION. THERE HAVE BEEN MULTIPLE STUDIES THAT HAVE COMBINED THE MANY ASPECTS OF YOGA INTO A GENERAL YOGA SESSION IN ORDER TO INVESTIGATE ITS EFFECTS ON MENOPAUSAL SYMPTOMS. INTEGRATED APPROACH OF YOGA THERAPY CAN IMPROVE HOT FLUSHES AND NIGHT SWEATS. THERE IS INCREASING EVIDENCE SUGGESTING THAT EVEN THE SHORT-TERM PRACTICE OF YOGA CAN DECREASE BOTH PSYCHOLOGICAL AND PHYSIOLOGICAL RISK FACTORS FOR CARDIOVASCULAR DISEASE (CVD). STUDIES CONCLUDE THAT OUR AGE OLD THERAPY, YOGA, IS FAIRLY EFFECTIVE IN MANAGING MENOPAUSAL SYMPTOMS. 2010 6 539 30 COMPLEMENTARY THERAPIES IN PARKINSON DISEASE: A REVIEW OF ACUPUNCTURE, TAI CHI, QI GONG, YOGA, AND CANNABIS. PARKINSON DISEASE (PD) IS A PROGRESSIVE NEURODEGENERATIVE CONDITION CHARACTERIZED BY BRADYKINESIA, RIGIDITY, RESTING TREMOR, AND POSTURAL INSTABILITY. NON-MOTOR SYMPTOMS, INCLUDING PAIN, FATIGUE, INSOMNIA, ANXIETY, AND DEPRESSION TO NAME A FEW, ARE INCREASINGLY RECOGNIZED AND OFTEN JUST AS DISABLING AT MOTOR SYMPTOMS. THE MAINSTAY OF TREATMENT IS DOPAMINE REPLACEMENT; HOWEVER, THE BENEFICIAL EFFECTS TEND TO WANE OVER TIME WITH DISEASE PROGRESSION, AND PATIENTS OFTEN EXPERIENCE MOTOR FLUCTUATIONS AND MEDICATION SIDE EFFECTS. THE LACK OF A DISEASE-MODIFYING INTERVENTION AND THE SHORTCOMINGS OF TRADITIONAL SYMPTOMATIC MEDICATIONS HAVE LED MANY PATIENTS TO PURSUE COMPLEMENTARY THERAPIES TO ALLEVIATE MOTOR AND NON-MOTOR SYMPTOMS ASSOCIATED WITH PD. THE TERM COMPLEMENTARY IMPLIES THAT THE THERAPY IS USED ALONG WITH CONVENTIONAL MEDICINE AND MAY INCLUDE SUPPLEMENTS, MANIPULATIVE TREATMENTS (CHIROPRACTIC, MASSAGE), EXERCISE-BASED PROGRAMS, AND MIND-BODY PRACTICES. AS THESE PRACTICES BECOME MORE WIDESPREAD IN WESTERN MEDICINE, THERE IS A GROWING INTEREST IN EVALUATING THEIR EFFECTS ON A NUMBER OF MEDICAL CONDITIONS, PD INCLUDED. IN THIS REVIEW, WE PROVIDE AN UPDATE ON CLINICAL TRIALS THAT HAVE EVALUATED THE EFFECTIVENESS OF COMPLEMENTARY TREATMENTS FOR PATIENTS WITH PD, SPECIFICALLY FOCUSING ON ACUPUNCTURE, TAI CHI, QI GONG, YOGA, AND CANNABIS. 2020 7 2636 32 YOGA FOR TREATING URINARY INCONTINENCE IN WOMEN. BACKGROUND: URINARY INCONTINENCE IN WOMEN IS ASSOCIATED WITH POOR QUALITY OF LIFE AND DIFFICULTIES IN SOCIAL, PSYCHOLOGICAL AND SEXUAL FUNCTIONING. THE CONDITION MAY AFFECT UP TO 15% OF MIDDLE-AGED OR OLDER WOMEN IN THE GENERAL POPULATION. CONSERVATIVE TREATMENTS SUCH AS LIFESTYLE INTERVENTIONS, BLADDER TRAINING AND PELVIC FLOOR MUSCLE TRAINING (USED EITHER ALONE OR IN COMBINATION WITH OTHER INTERVENTIONS) ARE THE INITIAL APPROACHES TO THE MANAGEMENT OF URINARY INCONTINENCE. MANY WOMEN ARE INTERESTED IN ADDITIONAL TREATMENTS SUCH AS YOGA, A SYSTEM OF PHILOSOPHY, LIFESTYLE AND PHYSICAL PRACTICE THAT ORIGINATED IN ANCIENT INDIA. OBJECTIVES: TO ASSESS THE EFFECTS OF YOGA FOR TREATING URINARY INCONTINENCE IN WOMEN. SEARCH METHODS: WE SEARCHED THE COCHRANE INCONTINENCE AND COCHRANE COMPLEMENTARY MEDICINE SPECIALISED REGISTERS. WE SEARCHED THE WORLD HEALTH ORGANIZATION INTERNATIONAL CLINICAL TRIALS REGISTRY PLATFORM (WHO ICTRP) AND CLINICALTRIALS.GOV TO IDENTIFY ANY ONGOING OR UNPUBLISHED STUDIES. WE HANDSEARCHED PROCEEDINGS OF THE INTERNATIONAL CONGRESS ON COMPLEMENTARY MEDICINE RESEARCH AND THE EUROPEAN CONGRESS FOR INTEGRATIVE MEDICINE. WE SEARCHED THE NHS ECONOMIC EVALUATION DATABASE FOR ECONOMIC STUDIES, AND SUPPLEMENTED THIS SEARCH WITH SEARCHES FOR ECONOMICS STUDIES IN MEDLINE AND EMBASE FROM 2015 ONWARDS. DATABASE SEARCHES ARE UP-TO-DATE AS OF 21 JUNE 2018. SELECTION CRITERIA: RANDOMISED CONTROLLED TRIALS IN WOMEN DIAGNOSED WITH URINARY INCONTINENCE IN WHICH ONE GROUP WAS ALLOCATED TO TREATMENT WITH YOGA. DATA COLLECTION AND ANALYSIS: TWO REVIEW AUTHORS INDEPENDENTLY SCREENED TITLES AND ABSTRACTS OF ALL RETRIEVED ARTICLES, SELECTED STUDIES FOR INCLUSION, EXTRACTED DATA, ASSESSED RISK OF BIAS AND EVALUATED THE CERTAINTY OF THE EVIDENCE FOR EACH REPORTED OUTCOME. ANY DISAGREEMENTS WERE RESOLVED BY CONSENSUS. WE PLANNED TO COMBINE CLINICALLY COMPARABLE STUDIES IN REVIEW MANAGER 5 USING RANDOM-EFFECTS META-ANALYSIS AND TO CARRY OUT SENSITIVITY AND SUBGROUP ANALYSES. WE PLANNED TO CREATE A TABLE LISTING ECONOMIC STUDIES ON YOGA FOR INCONTINENCE BUT NOT CARRY OUT ANY ANALYSES ON THESE STUDIES. MAIN RESULTS: WE INCLUDED TWO STUDIES (INVOLVING A TOTAL OF 49 WOMEN). EACH STUDY COMPARED YOGA TO A DIFFERENT COMPARATOR, THEREFORE WE WERE UNABLE TO COMBINE THE DATA IN A META-ANALYSIS. A THIRD STUDY THAT HAS BEEN COMPLETED BUT NOT YET FULLY REPORTED IS AWAITING ASSESSMENT.ONE INCLUDED STUDY WAS A SIX-WEEK STUDY COMPARING YOGA TO A WAITING LIST IN 19 WOMEN WITH EITHER URGENCY URINARY INCONTINENCE OR STRESS URINARY INCONTINENCE. WE JUDGED THE CERTAINTY OF THE EVIDENCE FOR ALL REPORTED OUTCOMES AS VERY LOW DUE TO PERFORMANCE BIAS, DETECTION BIAS, AND IMPRECISION. THE NUMBER OF WOMEN REPORTING CURE WAS NOT REPORTED. WE ARE UNCERTAIN WHETHER YOGA RESULTS IN SATISFACTION WITH CURE OR IMPROVEMENT OF INCONTINENCE (RISK RATIO (RR) 6.33, 95% CONFIDENCE INTERVAL (CI) 1.44 TO 27.88; AN INCREASE OF 592 FROM 111 PER 1000, 95% CI 160 TO 1000). WE ARE UNCERTAIN WHETHER THERE IS A DIFFERENCE BETWEEN YOGA AND WAITING LIST IN CONDITION-SPECIFIC QUALITY OF LIFE AS MEASURED ON THE INCONTINENCE IMPACT QUESTIONNAIRE SHORT FORM (MEAN DIFFERENCE (MD) 1.74, 95% CI -33.02 TO 36.50); THE NUMBER OF MICTURITIONS (MD -0.77, 95% CI -2.13 TO 0.59); THE NUMBER OF INCONTINENCE EPISODES (MD -1.57, 95% CI -2.83 TO -0.31); OR THE BOTHERSOMENESS OF INCONTINENCE AS MEASURED ON THE UROGENITAL DISTRESS INVENTORY 6 (MD -0.90, 95% CI -1.46 TO -0.34). THERE WAS NO EVIDENCE OF A DIFFERENCE IN THE NUMBER OF WOMEN WHO EXPERIENCED AT LEAST ONE ADVERSE EVENT (RISK DIFFERENCE 0%, 95% CI -38% TO 38%; NO DIFFERENCE FROM 222 PER 1000, 95% CI 380 FEWER TO 380 MORE).THE SECOND INCLUDED STUDY WAS AN EIGHT-WEEK STUDY IN 30 WOMEN WITH URGENCY URINARY INCONTINENCE THAT COMPARED MINDFULNESS-BASED STRESS REDUCTION (MBSR) TO AN ACTIVE CONTROL INTERVENTION OF YOGA CLASSES. THE STUDY WAS UNBLINDED, AND THERE WAS HIGH ATTRITION FROM BOTH STUDY ARMS FOR ALL OUTCOME ASSESSMENTS. WE JUDGED THE CERTAINTY OF THE EVIDENCE FOR ALL REPORTED OUTCOMES AS VERY LOW DUE TO PERFORMANCE BIAS, ATTRITION BIAS, IMPRECISION AND INDIRECTNESS. THE NUMBER OF WOMEN REPORTING CURE WAS NOT REPORTED. WE ARE UNCERTAIN WHETHER WOMEN IN THE YOGA GROUP WERE LESS LIKELY TO REPORT IMPROVEMENT IN INCONTINENCE AT EIGHT WEEKS COMPARED TO WOMEN IN THE MBSR GROUP (RR 0.09, 95% CI 0.01 TO 1.43; A DECREASE OF 419 FROM 461 PER 1000, 95% CI 5 TO 660). WE ARE UNCERTAIN ABOUT THE EFFECT OF MBSR COMPARED TO YOGA ON REPORTS OF CURE OR IMPROVEMENT IN INCONTINENCE, IMPROVEMENT IN CONDITION-SPECIFIC QUALITY OF LIFE MEASURED ON THE OVERACTIVE BLADDER HEALTH-RELATED QUALITY OF LIFE SCALE, REDUCTION IN INCONTINENCE EPISODES OR REDUCTION IN BOTHERSOMENESS OF INCONTINENCE AS MEASURED ON THE OVERACTIVE BLADDER SYMPTOM AND QUALITY OF LIFE-SHORT FORM AT EIGHT WEEKS. THE STUDY DID NOT REPORT ON ADVERSE EFFECTS. AUTHORS' CONCLUSIONS: WE IDENTIFIED FEW TRIALS ON YOGA FOR INCONTINENCE, AND THE EXISTING TRIALS WERE SMALL AND AT HIGH RISK OF BIAS. IN ADDITION, WE DID NOT FIND ANY STUDIES OF ECONOMIC OUTCOMES RELATED TO YOGA FOR URINARY INCONTINENCE. DUE TO THE LACK OF EVIDENCE TO ANSWER THE REVIEW QUESTION, WE ARE UNCERTAIN WHETHER YOGA IS USEFUL FOR WOMEN WITH URINARY INCONTINENCE. ADDITIONAL, WELL-CONDUCTED TRIALS WITH LARGER SAMPLE SIZES ARE NEEDED. 2019 8 2631 15 YOGA FOR THE TREATMENT OF INSOMNIA AMONG CANCER PATIENTS: EVIDENCE, MECHANISMS OF ACTION, AND CLINICAL RECOMMENDATIONS. UP TO 90% OF CANCER PATIENTS REPORT SYMPTOMS OF INSOMNIA DURING AND AFTER TREATMENT. SYMPTOMS OF INSOMNIA INCLUDE EXCESSIVE DAYTIME SLEEPINESS, DIFFICULTY FALLING ASLEEP, DIFFICULTY STAYING ASLEEP, AND WAKING UP TOO EARLY. INSOMNIA SYMPTOMS ARE AMONG THE MOST PREVALENT, DISTRESSING AND PERSISTENT CANCER- AND CANCER TREATMENT-RELATED TOXICITIES REPORTED BY PATIENTS, AND CAN BE SEVERE ENOUGH TO INCREASE CANCER MORBIDITY AND MORTALITY. DESPITE THE UBIQUITY OF INSOMNIA SYMPTOMS, THEY ARE UNDER-SCREENED, UNDER-DIAGNOSED, AND UNDER-TREATED IN CANCER PATIENTS. WHEN INSOMNIA SYMPTOMS ARE IDENTIFIED, PROVIDERS ARE HESITANT TO PRESCRIBE, AND PATIENTS ARE HESITANT TO TAKE PHARMACEUTICALS DUE TO POLYPHARMACY CONCERNS. IN ADDITION, SLEEP MEDICATIONS DO NOT CURE INSOMNIA. YOGA IS A WELL-TOLERATED MODE OF EXERCISE WITH PROMISING EVIDENCE FOR ITS EFFICACY IN IMPROVING INSOMNIA SYMPTOMS AMONG CANCER PATIENTS. THIS ARTICLE REVIEWS EXISTING CLINICAL RESEARCH ON THE EFFECTIVENESS OF YOGA FOR TREATING INSOMNIA AMONG CANCER PATIENTS. THE ARTICLE ALSO PROVIDES CLINICAL RECOMMENDATIONS FOR PRESCRIBING YOGA FOR THE TREATMENT OF INSOMNIA IN THIS POPULATION. 2014 9 1913 22 ROLE OF BREATHING EXERCISES IN ASTHMA-YOGA AND PRANAYAMA. ASTHMA IS A CHRONIC AIRWAY INFLAMMATORY DISEASE THAT RESULTS FROM A COMPLEX INTERPLAY OF GENETIC, ENVIRONMENTAL, AND LIFESTYLE FACTORS. THERE IS NO CURE FOR ASTHMA, AND THE MANAGEMENT IS USUALLY AS PER PUBLISHED GUIDELINES. AS IN MANY CHRONIC DISEASES CONDITIONS, VARIOUS ALTERNATIVE OR COMPLIMENTARY THERAPIES HAVE BEEN TRIED. OF THESE, YOGA AND PRANAYAMA HAVE GAINED WIDER ATTENTION IN RECENT YEARS. WHILE THE TERM YOGA IS A COMPLEX TERM ENCOMPASSING EIGHT LIMBS AS PER PATAMJAI IN THE YOGA SUTRAS, IN SIMPLE TERMS, YOGA IS DESCRIBED AS A COMBINATION OF 'ASANA' (PHYSICAL EXERCISES) AND 'PRANAYAMA' (BREATHING EXERCISE). THE TERM "ASTHMA" HAS BEEN DERIVED FROM THE GREEK WORD "PANTING,", WHICH INDICATES A RAPID AND SHALLOW BREATHING. THE MAIN AIM OF YOGA AND PRANAYAMA IN ASTHMA IS TO SYNCHRONIZE AND CONTROL BREATHING, THUS DECREASING HYPERVENTILATION. BESIDES THIS, THEY ALSO DECREASE THE STRESS/STRAIN/ANXIETY, CHANGE IN BEHAVIOR, BOOST IMMUNITY, AND IMPROVE STRENGTH/ENDURANCE OF RESPIRATORY MUSCLES THAT ARE HELPFUL IN ANY SUBJECT WITH ASTHMA. THERE HAVE BEEN A GOOD NUMBER OF STUDIES INCLUDING CLINICAL TRIALS IN CHILDREN WITH ASTHMA THAT HAVE FOUND SOME BENEFICIAL EFFECTS. IN THE PRESENT REVIEW, THE PHYSIOLOGY OF YOGA AND PRANAYAMA, RATIONALE FOR THEIR USE IN CHILDREN WITH ASTHMA ALONG WITH A SUMMARY OF VARIOUS STUDIES CONDUCTED TILL DATE, HAVE BEEN DISCUSSED. THESE ARE FOLLOWED BY RECOMMENDATIONS REGARDING THEIR INCORPORATION IN THE STANDARD OF CARE OF CHILDREN WITH ASTHMA. 2022 10 2503 22 YOGA AS TREATMENT FOR INSOMNIA AMONG CANCER PATIENTS AND SURVIVORS: A SYSTEMATIC REVIEW. MANY CANCER PATIENTS AND SURVIVORS, BETWEEN 15 TO 90%, REPORT SOME FORM OF INSOMNIA OR SLEEP QUALITY IMPAIRMENT DURING AND POST-TREATMENT, SUCH AS EXCESSIVE DAYTIME NAPPING, DIFFICULTY FALLING ASLEEP, DIFFICULTY STAYING ASLEEP, AND WAKING UP TOO EARLY. INSOMNIA AND SLEEP QUALITY IMPAIRMENT ARE AMONG THE MOST PREVALENT AND DISTRESSING PROBLEMS REPORTED BY CANCER PATIENTS AND SURVIVORS, AND CAN BE SEVERE ENOUGH TO INCREASE CANCER MORTALITY. DESPITE THE UBIQUITY OF INSOMNIA AND SLEEP QUALITY IMPAIRMENT, THEY ARE UNDER-DIAGNOSED AND UNDER-TREATED IN CANCER PATIENTS AND SURVIVORS. WHEN SLEEP PROBLEMS ARE PRESENT, PROVIDERS AND PATIENTS ARE OFTEN HESITANT TO PRESCRIBE OR TAKE PHARMACEUTICALS FOR SLEEP PROBLEMS DUE TO POLY PHARMACY CONCERNS, AND COGNITIVE BEHAVIORAL THERAPY FOR INSOMNIA CAN BE VERY DIFFICULT AND IMPRACTICAL FOR PATIENTS TO ADHERE TO THROUGHOUT THE CANCER EXPERIENCE. RESEARCH SUGGESTS YOGA IS A WELL-TOLERATED EXERCISE INTERVENTION WITH PROMISING EVIDENCE FOR ITS EFFICACY IN IMPROVING INSOMNIA AND SLEEP QUALITY IMPAIRMENT AMONG SURVIVORS. THIS ARTICLE PROVIDES A SYSTEMATIC REVIEW OF EXISTING CLINICAL RESEARCH ON THE EFFECTIVENESS OF YOGA FOR TREATING INSOMNIA AND SLEEP QUALITY IMPAIRMENT AMONG CANCER PATIENTS AND SURVIVORS. 2013 11 1927 22 ROLE OF YOGA IN CARDIAC DISEASE AND REHABILITATION. PURPOSE: CARDIOVASCULAR DISEASE CONTINUES TO BE THE LEADING CAUSE OF MORBIDITY AND MORTALITY AROUND THE WORLD. YOGA, A COMBINATION OF PHYSICAL POSTURES (ASANA), BREATHING EXERCISES (PRANAYAMA), AND MEDITATION (DHYANA), HAS GAINED INCREASING RECOGNITION AS A FORM OF MIND-BODY EXERCISE. IN THIS NARRATIVE REVIEW, WE INTENDED TO REVIEW THE EMERGING EVIDENCE ASSESSING THE PHYSIOLOGIC AND CLINICAL EFFECTS OF YOGA ON THE CARDIOVASCULAR SYSTEM AND THE POTENTIAL ROLE OF YOGA AS A COMPONENT OF COMPREHENSIVE CARDIAC REHABILITATION. METHODS: WE SEARCHED PUBMED, GOOGLE SCHOLAR, EMBASE, AND COCHRANE DATABASES FOR LITERATURE RELATED TO CARDIOVASCULAR EFFECTS OF YOGA FROM INCEPTION UP UNTIL 2017. RESULTS: YOGA HAS BEEN SHOWN TO HAVE FAVORABLE EFFECTS ON SYSTEMIC INFLAMMATION, STRESS, THE CARDIAC AUTONOMIC NERVOUS SYSTEM, AND TRADITIONAL AND EMERGING CARDIOVASCULAR RISK FACTORS. CONCLUSIONS: YOGA HAS SHOWN PROMISE AS A USEFUL LIFESTYLE INTERVENTION THAT CAN BE INCORPORATED INTO CARDIOVASCULAR DISEASE MANAGEMENT ALGORITHMS. ALTHOUGH MANY INVESTIGATORS HAVE REPORTED THE CLINICAL BENEFITS OF YOGA IN REDUCING CARDIOVASCULAR EVENTS, MORBIDITY, AND MORTALITY, EVIDENCE SUPPORTING THESE CONCLUSIONS IS SOMEWHAT LIMITED, THEREBY EMPHASIZING THE NEED FOR LARGE, WELL-DESIGNED RANDOMIZED TRIALS THAT MINIMIZE BIAS AND METHODOLOGICAL DRAWBACKS. 2019 12 1640 27 MOLECULAR SIGNATURE OF THE IMMUNE RESPONSE TO YOGA THERAPY IN STRESS-RELATED CHRONIC DISEASE CONDITIONS: AN INSIGHT. THE WORLD HEALTH ORGANIZATION DEFINES HEALTH AS COMPLETE WELL-BEING IN TERMS OF PHYSICAL, MENTAL AND SOCIAL, AND NOT MERELY THE ABSENCE OF DISEASE. TO ATTAIN THIS, INDIVIDUAL SHOULD ADAPT AND SELF-MANGE THE SOCIAL, PHYSICAL AND EMOTIONAL CHALLENGES OF LIFE. EXPOSURE TO CHRONIC STRESS DUE TO URBANIZATION, WORK STRESS, NUCLEAR FAMILY, POLLUTION, UNHEALTHY FOOD HABITS, LIFESTYLE, ACCIDENTAL DEATH IN THE FAMILY, AND NATURAL CALAMITIES ARE THE TRIGGERING FACTORS, LEADING TO HORMONAL IMBALANCE AND INFLAMMATION IN THE TISSUE. THE RELATIONSHIP BETWEEN STRESS AND ILLNESS IS COMPLEX; ALL CHRONIC ILLNESSES SUCH AS CARDIOVASCULAR DISEASE AND ASTHMA HAVE THEIR ROOT IN CHRONIC STRESS ATTRIBUTED BY INFLAMMATION. IN RECENT TIMES, YOGA THERAPY HAS EMERGED AS AN IMPORTANT COMPLEMENTARY ALTERNATIVE MEDICINE FOR MANY HUMAN DISEASES. YOGA THERAPY HAS A POSITIVE IMPACT ON MIND AND BODY; IT ACTS BY INCORPORATING APPROPRIATE BREATHING TECHNIQUES AND MINDFULNESS TO ATTAIN CONSCIOUS DIRECTION OF OUR AWARENESS OF THE PRESENT MOMENT BY MEDITATION, WHICH HELPS ACHIEVE HARMONY BETWEEN THE BODY AND MIND. STUDIES HAVE ALSO DEMONSTRATED THE IMPORTANT REGULATORY EFFECTS OF YOGA THERAPY ON BRAIN STRUCTURE AND FUNCTIONS. DESPITE THESE ADVANCES, THE CELLULAR AND MOLECULAR MECHANISMS BY WHICH YOGA THERAPY RENDERS ITS BENEFICIAL EFFECTS ARE INADEQUATELY KNOWN. A GROWING BODY OF EVIDENCE SUGGESTS THAT YOGA THERAPY HAS IMMUNOMODULATORY EFFECTS. HOWEVER, THE PRECISE MECHANISTIC BASIS HAS NOT BEEN ADDRESSED EMPIRICALLY. IN THIS REVIEW, WE HAVE ATTEMPTED TO HIGHLIGHT THE EFFECT OF YOGA THERAPY ON IMMUNE SYSTEM FUNCTIONING WITH AN AIM TO IDENTIFY IMPORTANT IMMUNOLOGICAL SIGNATURES THAT INDEX THE EFFECT OF YOGA THERAPY. TOWARD THIS, WE HAVE SUMMARIZED THE AVAILABLE SCIENTIFIC EVIDENCE SHOWING POSITIVE IMPACTS OF YOGA THERAPY. FINALLY, WE HAVE EMPHASIZED THE EFFICACY OF YOGA IN IMPROVING PHYSICAL AND MENTAL WELL-BEING. YOGA HAS BEEN A PART OF INDIAN CULTURE AND TRADITION FOR LONG; NOW, THE TIME HAS COME TO SCIENTIFICALLY VALIDATE THIS AND IMPLEMENT THIS AS AN ALTERNATIVE TREATMENT METHOD FOR STRESS-RELATED CHRONIC DISEASE. 2020 13 2454 24 YOGA AS A COMPLEMENTARY THERAPY FOR METABOLIC SYNDROME: A NARRATIVE REVIEW. METABOLIC SYNDROME (MS) IS ASSOCIATED WITH A SEDENTARY AND STRESSFUL LIFESTYLE AND AFFECTS UNDERACTIVE PEOPLE DISPROPORTIONATELY. YOGA IS CONSIDERED TO BE A LOW-IMPACT MIND-BODY STRESS-RELIEVING EXERCISE, AND RESEARCHERS ARE INCREASING THEIR FOCUS ON THE BENEFITS OF YOGA FOR MANAGING METABOLIC DISORDERS. IT IS ALSO IMPORTANT FOR PHYSICIANS AND HEALTH CARE PROFESSIONALS TO UNDERSTAND THE THERAPEUTIC EFFICACY OF YOGA INTERVENTION, IN TERMS OF ITS TYPE, DURATION AND FREQUENCY ON VARIOUS MS RISK FACTORS. THE PRESENT REVIEW SUMMARIZES THE CURRENT SCIENTIFIC UNDERSTANDING OF THE EFFECTS OF YOGA ON MS RISK FACTORS SUCH AS GLUCOSE HOMEOSTASIS MARKERS, LIPID PROFILE, ADIPOCYTOKINES AND CARDIOVASCULAR RISK FACTORS, AND DISCUSSES THE POSSIBLE MECHANISMS OF ACTION. MEDLINE, PUBMED, SCOPUS AND COCHRANE LIBRARY WERE SEARCHED FROM THEIR INCEPTION UP TO DECEMBER 2019, USING THE KEYWORDS "METABOLIC SYNDROME," "DIABETES," "CARDIOVASCULAR DISEASES," "OBESITY" AND "YOGA." THE LITERATURE SUMMARIZED IN THIS REVIEW HAVE SHOWN MIXED EFFECTS OF YOGA ON MS RISK FACTORS AND DO NOT PROVIDE ROBUST EVIDENCE FOR ITS EFFICACY. MORE RIGOROUS RESEARCH AND WELL-DESIGNED TRIALS THAT HAVE A HIGHER STANDARD OF METHODOLOGY AND EVALUATE YOGA'S LONG-TERM IMPACTS ON MS ARE NEEDED. UNDERSTANDING YOGA'S BIOCHEMICAL AND MOLECULAR MECHANISMS OF ACTION ON VARIOUS METABOLIC PATHWAYS IS ALSO NEEDED. 2021 14 1566 13 LOW BACK PAIN AND YOGA. ABSTRACT QUESTIONS FROM PATIENTS ABOUT PAIN CONDITIONS AND ANALGESIC PHARMACOTHERAPY AND RESPONSES FROM AUTHORS ARE PRESENTED TO HELP EDUCATE PATIENTS AND MAKE THEM MORE EFFECTIVE SELF-ADVOCATES. THE TOPIC ADDRESSED IN THIS ISSUE IS CHRONIC LOW BACK PAIN, ONE OF THE MOST COMMON REASONS TO VISIT ONE'S PRIMARY CARE DOCTOR. COMPLEMENTARY APPROACHES, INCLUDING YOGA, WILL BE ADDRESSED. 2014 15 2277 25 THE ROLES OF EXERCISE AND YOGA IN AMELIORATING DEPRESSION AS A RISK FACTOR FOR COGNITIVE DECLINE. CURRENTLY, THERE ARE NO EFFECTIVE PHARMACEUTICAL TREATMENTS TO REDUCE COGNITIVE DECLINE OR PREVENT DEMENTIA. AT THE SAME TIME, THE GLOBAL POPULATION IS AGING, AND RATES OF DEMENTIA AND MILD COGNITIVE IMPAIRMENT (MCI) ARE ON THE RISE. AS SUCH, THERE IS AN INCREASING INTEREST IN COMPLEMENTARY AND ALTERNATIVE INTERVENTIONS TO TREAT OR REDUCE THE RISK OF COGNITIVE DECLINE. DEPRESSION IS ONE POTENTIALLY MODIFIABLE RISK FACTOR FOR COGNITIVE DECLINE AND DEMENTIA. NOTABLY, EXERCISE AND YOGA ARE TWO INTERVENTIONS KNOWN TO BOTH REDUCE SYMPTOMS OF DEPRESSION AND IMPROVE COGNITIVE FUNCTION. THE CURRENT REVIEW DISCUSSES THE EFFICACY OF EXERCISE AND YOGA TO AMELIORATE DEPRESSION AND THEREBY REDUCE THE RISK OF COGNITIVE DECLINE AND POTENTIALLY PREVENT DEMENTIA. POTENTIAL MECHANISMS OF CHANGE, TREATMENT IMPLICATIONS, AND FUTURE DIRECTIONS ARE DISCUSSED. 2016 16 2023 30 SYSTEMATIC REVIEW OF YOGA FOR SYMPTOM MANAGEMENT DURING CONVENTIONAL TREATMENT OF BREAST CANCER PATIENTS. INTRODUCTION: BREAST CANCER IS ONE OF THE MOST COMMONLY DIAGNOSED CANCERS IN WOMEN IN THE US, AND ITS TREATMENTS HAVE SIGNIFICANT PHYSICAL AND PSYCHOLOGICAL SIDE EFFECTS AND LONG-TERM COMPLICATIONS CAUSING SIGNIFICANT MORBIDITY AND DECREASED QUALITY OF LIFE. INTEGRATIVE MEDICINE MODALITIES, SUCH AS YOGA, HAVE BEEN FOUND TO REDUCE SIDE EFFECTS OF CONVENTIONAL TREATMENTS WITHOUT INTERFERING WITH THE TREATMENT ITSELF AND IMPROVE QUALITY OF LIFE. IN THIS SYSTEMATIC REVIEW, WE SPECIFICALLY EXPLORED YOGA AS A POTENTIAL OPTION FOR SYMPTOMATIC MANAGEMENT IN PATIENTS UNDERGOING CONVENTIONAL BREAST CANCER TREATMENTS. METHODS: WE PERFORMED A LITERATURE SEARCH THAT WAS CONDUCTED TO INCLUDE THE DATABASES PUBMED, PSYCHINFO, COCHRANE LIBRARY, SCOPUS, AND CINAHL, RESULTING IN 28 RANDOMIZED CONTROLLED TRIAL (RCT) ARTICLES. WE REVIEW THE RESULTS OF THESE TRIALS REGARDING THE IMPACT OF YOGA IN THIS PATIENT POPULATION. RESULTS: OVERALL, THE MAJORITY OF THE RCT ARTICLES SHOWED SIGNIFICANT BENEFITS OF YOGA INTERVENTION IN VARIOUS ASPECTS OF QUALITY OF LIFE, FATIGUE, NAUSEA/VOMITING, SLEEP QUALITY, ANXIETY, DEPRESSION, AND DISTRESS. THERE ARE SEVERAL STUDIES THAT HAVE EXPLORED THE PHYSIOLOGICAL MECHANISM BEHIND THE EFFECTS OF YOGA AND FOUND THAT YOGA AFFECTS BOTH THE IMMUNE RESPONSE AND INFLAMMATION. DISCUSSION: THESE STUDIES REVEALED THAT YOGA HAS A POTENTIAL THERAPEUTIC ROLE IN THE SYMPTOMATIC MANAGEMENT OF BREAST CANCER PATIENTS, ENHANCING QUALITY OF LIFE DURING TREATMENT AS WELL AS IMPROVING ADHERENCE TO TREATMENT. FUTURE STUDIES WITH MORE DEFINED AND CONSISTENT METHODOLOGIES ARE NECESSARY TO FULLY UNDERSTAND THE POTENTIAL USE OF YOGA THERAPY IN PATIENTS WITH BREAST CANCER. 2022 17 2035 21 TELE-YOGA FOR CHRONIC PAIN: CURRENT STATUS AND FUTURE DIRECTIONS. PAIN IS A PERVASIVE, DEBILITATING DISORDER THAT IS RESISTANT TO LONG-TERM PHARMACOLOGICAL INTERVENTIONS. ALTHOUGH PSYCHOLOGICAL THERAPIES SUCH AS COGNITIVE BEHAVIOR THERAPY DEMONSTRATE MODERATE EFFICACY, MANY INDIVIDUALS CONTINUE TO HAVE ONGOING DIFFICULTIES FOLLOWING TREATMENT. THERE IS A CURRENT TREND TO ESTABLISH COMPLEMENTARY AND INTEGRATIVE HEALTH INTERVENTIONS FOR CHRONIC PAIN, FOR WHICH YOGA HAS BEEN FOUND TO HAVE EXCITING POTENTIAL. NEVERTHELESS, AN IMPORTANT CONSIDERATION WITHIN THE FIELD IS ACCESSIBILITY TO ADEQUATE CARE. TELEHEALTH CAN BE USED TO PROVIDE REAL-TIME INTERACTIVE VIDEO CONFERENCING LEADING TO INCREASED ACCESS TO HEALTH CARE FOR INDIVIDUALS LOCATED REMOTELY OR WHO OTHERWISE HAVE DIFFICULTY ACCESSING SERVICES, PERHAPS THROUGH ISSUES OF MOBILITY OR PROXIMITY OF ADEQUATE SERVICES. THIS ARTICLE ASSESSES THE CURRENT STATUS AND FEASIBILITY OF IMPLEMENTING TELE-YOGA FOR CHRONIC PAIN. METHODOLOGICAL LIMITATIONS AND RECOMMENDATIONS FOR FUTURE RESEARCH ARE DISCUSSED. 2018 18 2486 28 YOGA AS AN INTEGRATIVE APPROACH FOR PREVENTION AND TREATMENT OF ORAL CANCER. DESPITE TREMENDOUS ADVANCEMENTS IN MEDICINE, THE NUMBER OF ORAL CANCER CASES CONTINUES TO INCREASE, AND THE NEED FOR INTEGRATING ALTERNATE MEDICINE OR ADOPTING AN INTEGRATIVE APPROACH HAS BECOME A COMPELLING COST-EFFECTIVE REQUIREMENT FOR THE MANAGEMENT AND TREATMENT OF DISEASES. CONVENTIONAL TREATMENT OF ORAL CANCER INVOLVES SURGERY FOLLOWED BY RADIOTHERAPY WITH OR WITHOUT CHEMOTHERAPY WHICH CAUSES SEVERAL COMPLICATIONS INCLUDING POOR QUALITY OF LIFE AND HIGH CHANCES OF RECURRENCE OF CANCER. ORAL CANCER IS OFTEN LINKED WITH OBESITY WHICH IS MAJOR RISK FACTORS IN OTHER CANCERS. APART FROM OBESITY, ORAL CANCER IS THOUGHT TO HAVE AN INVERSE RELATION WITH NEURODEGENERATIVE DISORDERS PRESUMABLY BECAUSE CELL DEATH DECREASES IN THE FORMER CASE AND INCREASES IN THE LATTER. ANCIENT MIND-BODY TECHNIQUES SUCH AS YOGA HAVE NOT BEEN ADEQUATELY TESTED AS A TOOL TO SYNERGIZE THE CELLULAR EQUILIBRIUM PERTAINING TO THE TREATMENT OF ORAL CANCER. NERVE GROWTH FACTOR (NGF), TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA), AND INTERLEUKIN-6 (IL-6) ARE AMONG THE EARLY EXPERIMENTAL CELLULAR BIOMARKERS THAT MAY BE USED TO PROBE THE MODULATION OF ORAL CANCER, OBESITY, AND NEURODEGENERATIVE DISORDERS. YOGA HAS BEEN REPORTED TO INFLUENCE THESE MOLECULES IN HEALTHY INDIVIDUALS BUT WHETHER THEIR EXPRESSION CAN BE ALTERED IN PATIENTS OF ORAL CANCER BY YOGA INTERVENTION IS THE SUBJECT OF THIS RESEARCH BEING DISCUSSED IN THIS REVIEW ARTICLE. THEREFORE, THE PRESENT ARTICLE NOT ONLY REVIEWS THE CURRENT STATUS OF RESEARCH STUDIES IN ORAL CANCER, OBESITY, AND NEURODEGENERATIVE DISORDERS BUT ALSO HOW THESE ARE LINKED TO EACH OTHER AND WHY THE INVESTIGATIONS OF THE PUTATIVE NGF PATHWAY, INVOLVING TNF-ALPHA AND IL-6, COULD PROVIDE USEFUL CLUES TO UNDERSTAND THE MOLECULAR EFFECTS BROUGHT ABOUT BY YOGA INTERVENTION IN SUCH PATIENTS. 2018 19 2014 19 SUDARSHAN KRIYA YOGA: BREATHING FOR HEALTH. BREATHING TECHNIQUES ARE REGULARLY RECOMMENDED FOR RELAXATION, STRESS MANAGEMENT, CONTROL OF PSYCHOPHYSIOLOGICAL STATES, AND TO IMPROVE ORGAN FUNCTION. YOGIC BREATHING, DEFINED AS A MANIPULATION OF BREATH MOVEMENT, HAS BEEN SHOWN TO POSITIVELY AFFECT IMMUNE FUNCTION, AUTONOMIC NERVOUS SYSTEM IMBALANCES, AND PSYCHOLOGICAL OR STRESS-RELATED DISORDERS. THE AIM OF THIS STUDY WAS TO ASSESS AND PROVIDE A COMPREHENSIVE REVIEW OF THE PHYSIOLOGICAL MECHANISMS, THE MIND-BODY CONNECTION, AND THE BENEFITS OF SUDARSHAN KRIYA YOGA (SKY) IN A WIDE RANGE OF CLINICAL CONDITIONS. VARIOUS ONLINE DATABASES SEARCHED WERE MEDLINE, PSYCHINFO, EMBASE, AND GOOGLE SCHOLAR. ALL THE RESULTS WERE CAREFULLY SCREENED AND ARTICLES ON SKY WERE SELECTED. THE REFERENCES FROM THESE ARTICLES WERE CHECKED TO FIND ANY OTHER POTENTIALLY RELEVANT ARTICLES. SKY, A UNIQUE YOGIC BREATHING PRACTICE, INVOLVES SEVERAL TYPES OF CYCLICAL BREATHING PATTERNS, RANGING FROM SLOW AND CALMING TO RAPID AND STIMULATING. THERE IS MOUNTING EVIDENCE TO SUGGEST THAT SKY CAN BE A BENEFICIAL, LOW-RISK, LOW-COST ADJUNCT TO THE TREATMENT OF STRESS, ANXIETY, POST-TRAUMATIC STRESS DISORDER, DEPRESSION, STRESS-RELATED MEDICAL ILLNESSES, SUBSTANCE ABUSE, AND REHABILITATION OF CRIMINAL OFFENDERS. 2013 20 2764 24 YOGA PROGRAMME FOR TYPE-2 DIABETES PREVENTION (YOGA-DP) AMONG HIGH RISK PEOPLE IN INDIA: A MULTICENTRE FEASIBILITY RANDOMISED CONTROLLED TRIAL PROTOCOL. INTRODUCTION: A HUGE POPULATION IN INDIA IS AT HIGH RISK OF TYPE-2 DIABETES (T2DM). PHYSICAL ACTIVITY AND A HEALTHY DIET (HEALTHY LIFESTYLE) IMPROVE BLOOD GLUCOSE LEVELS IN PEOPLE AT HIGH RISK OF T2DM. HOWEVER, AN UNHEALTHY LIFESTYLE IS COMMON AMONG INDIANS. YOGA COVERS PHYSICAL ACTIVITY AND A HEALTHY DIET AND CAN HELP TO PREVENT T2DM. THE RESEARCH QUESTION TO BE ADDRESSED BY THE MAIN RANDOMISED CONTROLLED TRIAL (RCT) IS WHETHER A YOGA PROGRAMME FOR T2DM PREVENTION (YOGA-DP) IS EFFECTIVE IN PREVENTING T2DM AMONG HIGH RISK PEOPLE IN INDIA AS COMPARED WITH ENHANCED STANDARD CARE. IN THIS CURRENT STUDY, WE ARE DETERMINING THE FEASIBILITY OF UNDERTAKING THE MAIN RCT. INTERVENTION: YOGA-DP IS A STRUCTURED LIFESTYLE EDUCATION AND EXERCISE PROGRAMME. THE EXERCISE PART IS BASED ON YOGA AND INCLUDES SHITHILIKARANA VYAYAMA (LOOSENING EXERCISES), SURYA NAMASKAR (SUN SALUTATION EXERCISES), ASANA (YOGIC POSES), PRANAYAMA (BREATHING PRACTICES) AND DHYANA (MEDITATION) AND RELAXATION PRACTICES. METHODS AND ANALYSIS: THIS IS A MULTICENTRE, TWO-ARM, PARALLEL-GROUP, FEASIBILITY RCT WITH BLINDED OUTCOME ASSESSMENT AND INTEGRATED MIXED-METHODS PROCESS EVALUATION. ELIGIBLE PARTICIPANTS SHOULD BE AGED 18-74 YEARS, AT HIGH RISK OF T2DM (FASTING PLASMA GLUCOSE LEVEL 5.6-6.9 MMOL/L) AND SAFE TO PARTICIPATE IN PHYSICAL ACTIVITIES. AT LEAST 64 PARTICIPANTS WILL BE RANDOMISED TO INTERVENTION OR CONTROL GROUP WITH FINAL FOLLOW-UP AT 6 MONTHS. IMPORTANT PARAMETERS, NEEDED TO DESIGN THE MAIN RCT, WILL BE ESTIMATED, SUCH AS SD OF THE OUTCOME MEASURE (FASTING PLASMA GLUCOSE LEVEL AT 6-MONTH FOLLOW-UP), RECRUITMENT, INTERVENTION ADHERENCE, FOLLOW-UP, POTENTIAL CONTAMINATION AND TIME NEEDED TO CONDUCT THE STUDY. SEMISTRUCTURED QUALITATIVE INTERVIEWS WILL BE CONDUCTED WITH UP TO 20-30 PARTICIPANTS, A SAMPLE OF THOSE DECLINING TO PARTICIPATE, FOUR YOGA-DP INSTRUCTORS AND AROUND EIGHT STUDY STAFF TO EXPLORE THEIR PERCEPTIONS AND EXPERIENCES OF TAKING PART IN THE STUDY AND OF THE INTERVENTION, REASONS BEHIND NON-PARTICIPATION, EXPERIENCES OF DELIVERING THE INTERVENTION AND RUNNING THE STUDY, RESPECTIVELY. ETHICS AND DISSEMINATION: ETHICS APPROVAL HAS BEEN OBTAINED FROM THE FOLLOWING RESEARCH ETHICS COMMITTEES: FACULTY OF MEDICINE AND HEALTH SCIENCES, UNIVERSITY OF NOTTINGHAM (UK); CENTRE FOR CHRONIC DISEASE CONTROL (CCDC, INDIA); BAPU NATURE CURE HOSPITAL AND YOGASHRAM (BNCHY, INDIA) AND SWAMI VIVEKANANDA YOGA ANUSANDHANA SAMSTHANA (S-VYASA, INDIA). THE RESULTS WILL BE WIDELY DISSEMINATED AMONG KEY STAKEHOLDERS THROUGH VARIOUS AVENUES. TRIAL REGISTRATION NUMBER: CTRI/2019/05/018893. 2020